Dow Down 0.62% Nasdaq Down 1.14%

Inovio Pharmaceuticals, Inc. (INO)

-NasdaqGS
10.12 0.10(0.98%) Sep 22, 4:00PM EDT
Prev Close:10.22
Open:10.20
Bid:N/A
Ask:10.12 x 100
1y Target Est:21.00
Beta:3.39
Next Earnings Date:N/A
Day's Range:10.01 - 10.39
52wk Range:6.52 - 15.80
Volume:530,554
Avg Vol (3m):1,494,100
Market Cap:611.23M
P/E (ttm):N/A
EPS (ttm):-1.36
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
INODown 0.98%611.23M
AZN94.31B
PFE191.37B
SNY150.34B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):35.50
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.63
Quarterly EPS Est (Sep-14) :-0.14
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Inovio Pharmaceuticals, Inc., together with its subsidiaries, discovers, develops, and develops synthetic vaccines and immune therapies focusing on cancers and infectious diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback